Home » Authors » Jim Shrine

Articles by Jim Shrine

NIH Initiates Phase III Trial Of Avicena's Creatine Agent for PD

March 23, 2007

NIH Initiates Phase III Trial Of Avicena's Creatine Agent for PD

March 23, 2007

Avexa Raises $60.1M To Fund Phase III Trials Of HIV Agent

March 22, 2007

Australian biotechnology company Avexa Ltd. parlayed positive Phase IIb data on its lead HIV compound into a funding round that will total A$75 million (US$60.1 million). (BioWorld Today)

Avexa Raises $60.1M To Fund Phase III Trials Of HIV Agent

March 22, 2007

Australian biotechnology company Avexa Ltd. parlayed positive Phase IIb data on its lead HIV compound into a funding round that will total A$75 million (US$60.1 million). (BioWorld Today)

Alethia Enters Deal With Biosite For Ovarian Cancer Antibodies

March 14, 2007

Alethia Enters Deal With Biosite For Ovarian Cancer Antibodies

March 14, 2007

Neose Raising $43.3M Through A Placement Of Stock, Warrants

March 12, 2007

Neose Raising $43.3M Through A Placement Of Stock, Warrants

March 12, 2007

Avalon, Merck Collaborate To Work On Difficult Cancer Target

March 8, 2007

Avalon, Merck Collaborate To Work On Difficult Cancer Target

March 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...